FT AIpharma
Why AI can transform pharma — but nature cannot be hurried
Artificial intelligence has the potential to fundamentally change the development of new treatments
AI Insider·
Insider Brief PRESS RELEASE — Modicus Prime, a former resident at Johnson & Johnson Innovation — JLABS @ Texas Medical Center, has announced the completion of an additional $4.5M in funding led by Frist Cressey Ventures, bringing total funding to $8M with additional backing from Silverton Partners and Oncology Ventures. The funding comes following the multiple rollouts of the Trustworthy […]
Read full articleArtificial intelligence has the potential to fundamentally change the development of new treatments
Kyrok raised €3.1M in pre-seed funding led by Speedinvest to build an AI operating system for pharma and chemical supply chain teams.
Knit Health raised $11.6M from Uncork Capital and Frist Cressey Ventures to train AI on real clinician behavior across major U.S. health systems.